Literature DB >> 31195667

Metabolomic Investigation of β-Thalassemia in Chorionic Villi Samples.

Giovanni Monni1, Federica Murgia2, Valentina Corda3, Cristina Peddes4, Ambra Iuculano5, Laura Tronci6, Antonella Balsamo7, Luigi Atzori8.   

Abstract

BACKGROUND: Beta-thalassemias are blood disorders characterized by poorly understood clinical phenotypes ranging from asymptomatic to severe anemia. Metabolic composition of the human placenta could be affected by the presence of pathological states such as β-thalassemia. The aim of our study was to describe metabolic changes in chorionic villi samples of fetuses affected by β-thalassemia compared to a control group by applying a metabolomics approach.
METHODS: Chorionic villi samples were differentiated according to the genetic diagnosis of β-thalassemia: control (Group 1, n = 27); heterozygous (Group 2, n = 7); homozygous (Group 3, n = 7). Gas chromatography-mass spectrometry was used to detect the metabolic composition of the samples. Subsequently, multivariate and univariate statistical analysis was performed. The discriminant metabolites were used to identify the altered pathways.
RESULTS: Supervised multivariate models were devised to compare the groups. The model resulting from the comparison between Group 1 and Group 3 was the most significant. Discriminant metabolites were identified, and the most altered pathways were as follows: pentose phosphate pathway (PPP), arachidonic acid metabolism, glycolysis, and gluconeogenesis, suggesting the presence of an energetic shift toward the PPP and the presence of oxidative stress in β-thalassemia chorionic villi samples.
CONCLUSIONS: The metabolomics approach identified a specific metabolic fingerprint in chorionic villi of fetuses affected by β-thalassemia.

Entities:  

Keywords:  arachidonic acid metabolism; chorionic villi samples; gas chromatography–mass spectrometry; metabolomics; pentose phosphate pathway; β-thalassemia

Year:  2019        PMID: 31195667      PMCID: PMC6616561          DOI: 10.3390/jcm8060798

Source DB:  PubMed          Journal:  J Clin Med        ISSN: 2077-0383            Impact factor:   4.241


  28 in total

Review 1.  Screening for thalassemia: a model of success.

Authors:  Antonio Cao; Maria Cristina Rosatelli; Giovanni Monni; Renzo Galanello
Journal:  Obstet Gynecol Clin North Am       Date:  2002-06       Impact factor: 2.844

Review 2.  Metabolomics as a tool for cardiac research.

Authors:  Julian L Griffin; Helen Atherton; John Shockcor; Luigi Atzori
Journal:  Nat Rev Cardiol       Date:  2011-09-20       Impact factor: 32.419

3.  XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification.

Authors:  Colin A Smith; Elizabeth J Want; Grace O'Maille; Ruben Abagyan; Gary Siuzdak
Journal:  Anal Chem       Date:  2006-02-01       Impact factor: 6.986

Review 4.  Mass spectrometry-based metabolomics.

Authors:  Katja Dettmer; Pavel A Aronov; Bruce D Hammock
Journal:  Mass Spectrom Rev       Date:  2007 Jan-Feb       Impact factor: 10.946

Review 5.  The biochemistry, metabolism and inherited defects of the pentose phosphate pathway: a review.

Authors:  M M C Wamelink; E A Struys; C Jakobs
Journal:  J Inherit Metab Dis       Date:  2008-11-08       Impact factor: 4.982

Review 6.  Metabolomics in the developing human being.

Authors:  Aggeliki Syggelou; Nicoletta Iacovidou; Luigi Atzori; Theodoros Xanthos; Vassilios Fanos
Journal:  Pediatr Clin North Am       Date:  2012-10       Impact factor: 3.278

Review 7.  Phospholipases A2 in ischemic and toxic brain injury.

Authors:  A Sapirstein; J V Bonventre
Journal:  Neurochem Res       Date:  2000-05       Impact factor: 3.996

Review 8.  Oxidative stress and arachidonic acid mobilization.

Authors:  María A Balboa; Jesús Balsinde
Journal:  Biochim Biophys Acta       Date:  2006-04-19

Review 9.  Metabolomics-based methods for early disease diagnostics.

Authors:  G A Nagana Gowda; Shucha Zhang; Haiwei Gu; Vincent Asiago; Narasimhamurthy Shanaiah; Daniel Raftery
Journal:  Expert Rev Mol Diagn       Date:  2008-09       Impact factor: 5.225

10.  Oxidative stress in patients with beta-thalassemia major.

Authors:  L E Pavlova; V M Savov; H G Petkov; I P Charova
Journal:  Prilozi       Date:  2007-07
View more
  3 in total

1.  Amniotic fluid metabolomic and lipidomic alterations associated with hemoglobin Bart's diseases.

Authors:  Xiaohang Chen; Hongyan Chen; Haimei Nie; Gaochi Li; Jinjiang Su; Xianzhen Cao; Yongli Cao; Fengxiang Wei
Journal:  Metabolomics       Date:  2021-09-06       Impact factor: 4.290

2.  Proteomics and metabolomics analysis reveal potential mechanism of extended-spectrum β-lactamase production in Escherichia coli.

Authors:  He Ma; Bingjie Lai; Yufen Jin; Chang Tian; Jiaying Liu; Ke Wang
Journal:  RSC Adv       Date:  2020-07-17       Impact factor: 4.036

Review 3.  Metabolomics in Prenatal Medicine: A Review.

Authors:  Giovanni Monni; Luigi Atzori; Valentina Corda; Francesca Dessolis; Ambra Iuculano; K Joseph Hurt; Federica Murgia
Journal:  Front Med (Lausanne)       Date:  2021-06-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.